BMS’ and bluebird bio’s Abecma approved by US FDA; first CAR T cell therapy for multiple myeloma Bristol Myers Squibb and bluebird bio, Inc. announced that the US Food and Drug Administration approved Abecma (idecabtagene vicleucel;...
ROLE OF PHARMACY BENEFIT MANAGERS IN THE PRICING OF THE UNITED STATES Pharmacy Benefit Managers are third-party companies. Their primary role is to develop and maintain the formulary, negotiation of the...
Governments and other organizations raised US$ 8.8 billion at Global Vaccine Summit The Global Vaccine Summit hosted in the UK was successful in raising US$ 8.8 billion, more than the expected target of US$ 7.4 billion....
